5ThomasHV, LiH, MichaelM, et al. Elevtrical,morphological, and uhastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation[J]. Circulation, 2000,102:1454.
6Goette A, HoneycuttC, Langberg JJ. Electrical remodeling in atrial fibrillation:time course and mechanisms[J]. Circulation, 2001,103:724.
8MadridAH. Bueno MG, RebooloJM, et al. Use of ribesartan to maintain sinus rhythm in patients with long-lasting persistent artial fibrillation:a prospective and randomized study[Jl. Circulation, 2002, 106(3):331-336.
二级参考文献15
1Thomas HV, Li H, Michael M, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation[ J]. Circulation,2000,102 : 1 454.
2Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation : time course and mechanisms[ J ]. Circulation, 1996,94 :2 968.
3Tieleman RG, Langen CDJD, Gelder ICV, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria [ J ]. Circulation, 1997,95 : 1 945.
4Tieleman RG, Gelder ICV, Crijns HJGM,et al. Early recurrences of atrial fibrillation after electrical cardloversion: a result of fibrillationreduced electrical remodeling of atria[ J] ? J Am Coil Cardil, 1998,31 : 167.
5Hideko N, Koickiro K, Hidenori U, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation [ J ]. Circulation,2000,101:2 612.
6Pedersen OD, Bagger H, Kober L, et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction [ J ]. Circulation, 1999, 100:376.
7Van Den Berg MP, Crijns HJGM, Van Veldhuisen DJ, et al. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation[J]. J Card Fail,1995,1:355.
8Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in human [ J ]. Circulation,2000,101(23) :2 678.
9Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotension-converting enzyme in humn atria during atrial fibrillation[ J]. J Am Coil Cardiol,2000,35 : 1 669.
10De Simone A, Stabile G, Vitale DF, et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion [ J ]. J Am Coil Cardiol, 1999,34 : 810.
8Solomon SD , Verma A , Desai A , et al. Effect of intensive versusstandard blood pressure lowering on diastolic function in patientswith uncontroiled hypertension and diastolic dysfunction [ J ]. Hy-pertension ,2010,55( 1 ) :241 - 248.
9HirayamaY,Atarashi H,Kobayashi Y,et al.Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysma atrial fibrillation to chronic atrial fibrillation.Circ J,2005,69(6):671-676.
10Healey JS,Barancuk A,Crystal E,et al.Revertion of atrial filbrilation with angiotension-converting enzyme inhibitors and angiotension receptor blocks.J Am Coll Cardiol,2005,45(11):1832-1839.
